249 related articles for article (PubMed ID: 26614561)
21. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery.
Cano-Cebrián MJ; Zornoza T; Granero L; Polache A
Curr Drug Deliv; 2005 Jan; 2(1):9-22. PubMed ID: 16305404
[TBL] [Abstract][Full Text] [Related]
22. Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues.
Di Colo G; Zambito Y; Zaino C
J Pharm Sci; 2008 May; 97(5):1652-80. PubMed ID: 17828745
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional matrices for oral peptide delivery.
Bernkop-Schnürch A; Walker G
Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
[TBL] [Abstract][Full Text] [Related]
24. FRET-based dual-emission and pH-responsive nanocarriers for enhanced delivery of protein across intestinal epithelial cell barrier.
Lu KY; Lin CW; Hsu CH; Ho YC; Chuang EY; Sung HW; Mi FL
ACS Appl Mater Interfaces; 2014 Oct; 6(20):18275-89. PubMed ID: 25260022
[TBL] [Abstract][Full Text] [Related]
25. Strategies and industrial perspectives to improve oral absorption of biological macromolecules.
Liu C; Kou Y; Zhang X; Cheng H; Chen X; Mao S
Expert Opin Drug Deliv; 2018 Mar; 15(3):223-233. PubMed ID: 29111841
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
27. Polymeric micelles for oral drug delivery.
Gaucher G; Satturwar P; Jones MC; Furtos A; Leroux JC
Eur J Pharm Biopharm; 2010 Oct; 76(2):147-58. PubMed ID: 20600891
[TBL] [Abstract][Full Text] [Related]
28. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
George M; Abraham TE
J Control Release; 2006 Aug; 114(1):1-14. PubMed ID: 16828914
[TBL] [Abstract][Full Text] [Related]
29. Oral bioavailability of insulin contained in polysaccharide nanoparticles.
Sarmento B; Ribeiro A; Veiga F; Ferreira D; Neufeld R
Biomacromolecules; 2007 Oct; 8(10):3054-60. PubMed ID: 17877397
[TBL] [Abstract][Full Text] [Related]
30. Intestinal uptake of insulin nanoparticles: facts or myths?
Lopes MA; Abrahim BA; Seiça R; Veiga F; Rodrigues CR; Ribeiro AJ
Curr Pharm Biotechnol; 2014; 15(7):629-38. PubMed ID: 25219866
[TBL] [Abstract][Full Text] [Related]
31. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Ensign LM; Cone R; Hanes J
Adv Drug Deliv Rev; 2012 May; 64(6):557-70. PubMed ID: 22212900
[TBL] [Abstract][Full Text] [Related]
32. Oral peptide delivery: Translational challenges due to physiological effects.
Tyagi P; Pechenov S; Anand Subramony J
J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
[TBL] [Abstract][Full Text] [Related]
33. Targeted Gastrointestinal Delivery of Nutraceuticals with Polysaccharide-Based Coatings.
Sampathkumar K; Loo SCJ
Macromol Biosci; 2018 Apr; 18(4):e1700363. PubMed ID: 29479799
[TBL] [Abstract][Full Text] [Related]
34. Bioadhesion and oral absorption of enoxaparin nanocomplexes.
Sun W; Mao S; Wang Y; Junyaprasert VB; Zhang T; Na L; Wang J
Int J Pharm; 2010 Feb; 386(1-2):275-81. PubMed ID: 19958824
[TBL] [Abstract][Full Text] [Related]
35. pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery.
Mukhopadhyay P; Chakraborty S; Bhattacharya S; Mishra R; Kundu PP
Int J Biol Macromol; 2015 Jan; 72():640-8. PubMed ID: 25239194
[TBL] [Abstract][Full Text] [Related]
36. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
37. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
[TBL] [Abstract][Full Text] [Related]
38. Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins.
Sonaje K; Lin KJ; Tseng MT; Wey SP; Su FY; Chuang EY; Hsu CW; Chen CT; Sung HW
Biomaterials; 2011 Nov; 32(33):8712-21. PubMed ID: 21862121
[TBL] [Abstract][Full Text] [Related]
39. Chitosan in nasal delivery systems for therapeutic drugs.
Casettari L; Illum L
J Control Release; 2014 Sep; 190():189-200. PubMed ID: 24818769
[TBL] [Abstract][Full Text] [Related]
40. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
